Summary for Aminocaproic Acid


BreastfeedingPediatric
  • Trade Names: Amicar (Xanodyne); Capramol; Caproamin; Caprolisin; Ipron; Ipsilon; Resplamin
  • Indications: To provide hemostasis in the treatment of fibrinolysis
  • Class: Antifibrinolytic
  • Half-life: 1–2 hours
  • Clinically important, potentially hazardous interactions with:
    None known

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top